MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced new clinical findings indicating that its lead candidate, buntanetap, reduces inflammation and improves cellular health in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback